Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7255 results

Sort By:

At-Home Cardiac Rehabilitation for Adolescents at Risk for Heart Failure

Study ID: NCT06826534
Start Date: 2023-10-20
End Date: 2025-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Cardio-oncology rehabilitation

Sponsor

Children's Hospital Los Angeles

Source: clinicaltrials.gov

Share:
Add to list

MIRAI-MRI: Comparing Screening MRI for Patients at High Risk for Breast Cancer Identified by Mirai and Tyrer-Cuzick

Study ID: NCT05968157
Start Date: 2024-02-04
End Date: 2027-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Breast MRI

MIRAI

Sponsor

University of Massachusetts, Worcester

Source: clinicaltrials.gov

Share:
Add to list

Lymphedema Surveillance Study

Study ID: NCT02743858
Start Date: 2016-04
End Date: 2026-04
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1250

Intervention / Treatment

Bilateral arm measurements

Body mass index (BMI)

Quality of Life Questionnaire

Blood draw

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

International PPB/DICER1 Registry

Study ID: NCT03382158
Start Date: 2016-12-06
End Date: 2035-12-06
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

3400

Intervention / Treatment
Sponsor

Children's Hospitals and Clinics of Minnesota

Source: clinicaltrials.gov

Share:
Add to list

Improving Cancer Prevention and Control Through Academic-local Public Health Department Partnerships

Study ID: NCT06605196
Start Date: 2025-02-03
End Date: 2027-04-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

364

Intervention / Treatment

Resources and guided facilitation

Existing resources

Sponsor

Washington University School of Medicine

Source: clinicaltrials.gov

Share:
Add to list

A Phase 2 Study of Epcoritamab, Zanubrutinib, and Rituximab (EZR) for Treatment of Relapsed or Refractory Follicular Lymphoma or Marginal Zone Lymphoma

Study ID: NCT06563596
Start Date: 2025-01-21
End Date: 2030-03-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

45

Intervention / Treatment

Zanubrutinib

Rituximab

Epcoritamab

Sponsor

Reid Merryman, MD

Source: clinicaltrials.gov

Share:
Add to list

Two Fraction Prostate SBRT With DIL SIB

Study ID: NCT05864196
Start Date: 2023-07-17
End Date: 2026-06
Study Type

Interventional

Study Phase

Phase1

No. of Participants

80

Intervention / Treatment

Two-Fraction Stereotactic Body Radiation Therapy (SBRT)

Sponsor

NYU Langone Health

Source: clinicaltrials.gov

Share:
Add to list

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

Study ID: NCT03435796
Start Date: 2018-07-19
End Date: 2036-11-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1541

Intervention / Treatment

Gene-modified (GM) T cell therapy

Sponsor

Celgene

Source: clinicaltrials.gov

Share:
Add to list

BREAST Choice Decision Tool R21

Study ID: NCT06817226
Start Date: 2024-10-10
End Date: 2025-08
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Assess decision making context.

Solicit input from the target population

Integration and refinemen of the decision aid

Sponsor

UNC Lineberger Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas

Study ID: NCT04275557
Start Date: 2020-02-18
End Date: 2027-06
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1174

Intervention / Treatment

Blood Sample collection

Tissue sample collection

Data collection

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Source: clinicaltrials.gov

Share:
Add to list